The consensus estimate for Q4 2025 revenue is $0.03 billion, and the earnings are expected to come in at -$0.42 per share. The full year 2025's revenue is expected to be $0.10 billion, and the ...
Zacks Investment Research on MSN
Beta Bionics, Inc. (BBNX) reports Q4 loss, tops revenue estimates
Beta Bionics, Inc. (BBNX) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $1.82 per share a year ago. These figures ...
Beta is a measurement of an asset’s risk compared to a benchmark, like the stock market. The market or benchmark used to calculate an asset’s beta always has a beta of 1. Stocks that have a return ...
Investors understand intuitively that some stocks are riskier than others. The capital asset pricing model attempts to quantify the common perception of risk using a term called beta. By understanding ...
Discover why unlevering beta is essential in WACC calculations for comparing debt and equity financing costs effectively.
Every investor strives to balance two conflicting goals: Maximizing their investment returns and minimizing their risk. Beta offers a way to measure the amount of risk you’re taking on for a given ...
Investors, whether beginner or seasoned professionals, all have a threshold for risk. Some prefer to play it safe and favor a low-risk investment plan while others are more advantageous with a “high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results